Smoking accelerates the progression of hypertension-induced myocardial hypertrophy to heart failure in spontaneously hypertensive rats

Cardiovascular Research

Volumn 76, Issue 2, 2007, Pages 311-322

  Meurrens, K ^a   Ruf, S ^b   Ross, G ^b   Schleef, R ^c   von Holt, K ^d   Schluter K D ^b  

^a Philip Morris Research Laboratories   (Belgium)

^b JUSTUS LIEBIG UNIVERSITY   (Germany)

^c Philip Morris USA   (United States)

^d Philip Morris Research Laboratories GmbH   (Germany)

Author keywords

Ischemia; ODC; PTHrP; Reperfusion; TGF 1

Indexed keywords

ATRIAL NATRIURETIC FACTOR; ISOPRENALINE; MESSENGER RNA; ORNITHINE DECARBOXYLASE; PARATHYROID HORMONE RELATED PROTEIN; TRANSFORMING GROWTH FACTOR BETA1;

AIR; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CARDIOVASCULAR RISK; CIGARETTE SMOKING; CONTROLLED STUDY; CONVALESCENCE; DISEASE COURSE; ENVIRONMENTAL EXPOSURE; HEART FAILURE; HEART MUSCLE ISCHEMIA; HEART STIMULATION; HEART VENTRICLE HYPERTROPHY; HEART WEIGHT; HYPERTENSION; INOTROPISM; MALE; NONHUMAN; PARTICULATE MATTER; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REPERFUSION; SMOKING CESSATION; SPONTANEOUSLY HYPERTENSIVE RAT;

ANIMALS; CARDIOMEGALY; DISEASE PROGRESSION; HEART FAILURE; HYPERTENSION; MALE; MYOCARDIAL ISCHEMIA; PARATHYROID HORMONE-RELATED PROTEIN; RATS; RATS, INBRED SHR; RATS, INBRED WKY; RECEPTORS, ADRENERGIC, BETA; SMOKING; TRANSFORMING GROWTH FACTOR BETA1; VENTRICULAR FUNCTION, LEFT;

EID: 36649017241     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cardiores.2007.06.033     Document Type: Article

References (28)

1. Levy D., Garrison R.J., Svadage D.D., Kannel W.B., and Catselli W.P. Prognostic implications of echocardiography determined left ventricular mass in the Framingham Heart Study. N Engl J Med 322 (1990) 1561-1566
2. Frey N., and Olson E.N. Cardiac hypertrophy: the good, the bad and the ugly. Annu Rev Physiol 65 (2003) 45-79
3. Selvetella G., Hirsch E., Notte A., Tarone G., and Lembo G. Adaptive and maladaptive hypertrophic pathways: points of convergence and divergence. Cardiovasc Res 63 (2004) 373-380
4. Okamoto K. Spontaneously hypertension in rats. Int Rev Exp Pathol 7 (1969) 227-270
5. Trippodo N.C., and Frohlich E.D. Similarities of genetic (spontaneously) hypertension. Man and rat. Circ Res 48 (1981) 309-319
6. Swislocki A., and Tsuzuki A. Insulin resistance and hypertension: glucose intolerance, hyperinsulinemia, and elevated free fatty acids in the lean spontaneously hypertensive rat. Am J Med Sci 306 (1993) 282-286
7. Boluyt M.O., O'Neill L., Meredith A.L., Bing O.H.L., Brooks W.W., Conrad C.H., et al. Alterations in cardiac gene expression during the transition from stable hypertrophy to heart failure. Circ Res 75 (1994) 23-32
8. 1 receptor antagonist, an ACE inhibitor and a calcium channel antagonist on cardiac gene expressions in hypertensive rats. Br J Pharmacol 118 (1996) 549-556
9. 1 expression in adult ventricular cardiomyocytes. FASEB J 15 (2001) 2291-2293
10. Schlüter K.-D., Zhou X.J., and Piper H.M. Induction of hypertrophic responsiveness to isoproterenol by TGF-β in adult rat cardiomyocytes. Am J Physiol Cell Physiol 269 (1995) C1311-C1316
11. 2-adrenoceptor stimulation on adult ventricular cardiomyocytes. Mol Cell Biochem 163/164 (1996) 211-216
12. Schlüter K.-D., Frischkopf K., Flesch M., Rosenkranz S., Taimor G., and Piper H.M. Central role for ornithine decarboxylase in β-adrenoceptor mediated hypertrophy. Cardiovasc Res 45 (2000) 410-417
13. 1 downregulates PTHrP in coronary endothelial cells. J Mol Cell Cardiol 33 (2001) 1181-1190
14. Degenhardt H., and Schlüter K.-D. The role of parathyroid hormone-related peptide in endothelium-dependent regulation of cardiac function. Curr Top Pept Protein Res 6 (2004) 105-113
15. Clemens T.L., Cornier S., Eichinger A., Endlich K., Fiaschi-Taesch N., Fischer E., et al. Parathyroid hormone-related protein and its receptors: nuclear functions and roles in the renal and cardiovascular systems, the placental trophoblasts and the pancreatic islets. Br J Pharmacol 134 (2001) 1113-1136
16. Snoeckx L.H., van der Vusse G.J., Coumans W.A., Willemsen P.H., and Renemans R.S. Differences in ischemia tolerance between hypertrophied hearts of adult and aged spontaneously hypertensive rats. Cardiovasc Res 27 (1993) 874-881
17. Grohé C., van Eickels M., Wenzel S., Meyer R., Degenhardt H., Doevendans P.A., et al. Sex-specific differences in ventricular expression and function of parathyroid hormone-related peptide. Cardiovasc Res 61 (2004) 307-316
18. Schlüter K.-D., Katzer C., Frischkopf K., Wenzel S., Taimor G., and Piper H.M. Expression, release, and biological activity of parathyroid hormone-related peptide from coronary endothelial cells. Circ Res 86 (2000) 946-951
19. Ross G., and Schlüter K.-D. Cardiac-specific effects of parathyroid hormone-related peptide: modification by aging and hypertension. Cardiovasc Res 66 (2005) 334-344
20. Glantz S.A., and Parmley W.W. Passive smoke and heart disease. Circulation 83 (1991) 1-12
21. Zhu B.Q., Sun Y.P., Sievers R.E., Stanton A.G., Parmley W.W., and Wolfe C.L. Exposure to environmental tobacco smoke increases myocardial infarct size in rats. Circulation 89 (1994) 1282-1290
22. van Jaarsveld H., Kuyl J.M., and Alberts D.W. Exposure of rats to low concentration of cigarette smoke increases myocardial sensitivity to ischemia/reperfusion. Basic Res Cardiol 87 (1992) 393-399
23. Zimmermann R., Kastens J., Linz W., Wiemer G., Schölkens B.A., and Schaper J. Effect of long-term ACE inhibition on myocardial tissue in hypertensive stroke-prone rats. J Mol Cell Cardiol 31 (1999) 1447-1456
24. van Eickels M., Schreckenberg R., Doevendans P.A., Meyer R., Grohé C., and Schlüter K.-D. The influence of oestrogen-deficiency and ACE inhibition on the progression of myocardial hypertrophy in spontaneously hypertensive rats. Eur J Heart Fail 7 (2005) 1079-1084
25. Massfelder T., Dann P., Wu T.L., Vasavada R., Helwig J.J., and Stewart A.F. Opposing mitogenic and anti-mitogenic actions of parathyroid hormone-related protein in vascular smooth muscle cells: a critical role for nuclear targeting. Proc Natl Acad Sci U S A 94 (1997) 13630-13635
26. Friehs I., and del Nido P.J. Increased susceptibility of hypertrophied hearts to ischemic injury. Ann Thorac Surg 75 2 (2003) S678-S684
27. Bolli R., Becker L., Gross G., Mentzer Jr. R., Balshaw D., and Lathrop D.A. Myocardial protection at a crossroads. The need for translation into clinical therapy. Circ Res 95 (2004) 125-134
28. Ross G., Engel P., Abdallah Y., Kummer W., and Schlüter K.-D. Tuberoinfundibular peptide of 39 residues: a new mediator of cardiac function via nitric oxide production in the rat heart. Endocrinology 146 (2005) 2221-2228